-
WellCare of New Jersey Announces Actions to Further Protect Members from COVID-19
prnewswire
August 24, 2021
WellCare of New Jersey announced today it is taking additional measures to further protect its members from COVID-19.
-
Global Contract Logistics Markets Report 2021: By 2025, the Market will be 24% Larger than Before COVID-19
prnewswire
August 24, 2021
The global contract logistics market contracted by 3.3% in 2020, ending a decade-long growth streak.
-
Delta Variant Has Americans' Stress Levels Rising Again: Poll
drugs
August 23, 2021
As coronavirus cases spike in the United States due to the highly contagious Delta variant, a new poll finds Americans' anxiety about COVID-19 at its highest since January.
-
Long-Haul COVID-19 May Affect Two of Three With Mild, Moderate Disease
drugs
August 23, 2021
The majority of individuals who experience mild or moderate COVID-19infection have persistent symptoms more than 30 days after diagnosis, according to a study published online Aug. 4 in PLOS ONE.
-
Decision on J&J COVID-19 Vaccine Booster Doses Could Take Weeks
drugs
August 23, 2021
A decision on booster shots for the approximately 13.8 million Americans who received the Johnson & Johnson single-shot COVID-19 vaccine is likely to take weeks, according to people familiar with the issue.
-
TGA provisionally approves GlaxoSmithKline's COVID-19 treatment: sotrovimab (XEVUDY)
firstwordpharma
August 23, 2021
On 20 August 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval to GlaxoSmithKline (GSK) Australia Pty Ltd for its COVID-19 treatment - sotrovimab (XEVUDY) - making it the second COVID-19.
-
Cuba grants emergency approval to second homegrown vaccine
firstwordpharma
August 23, 2021
Cuba's Center for State Control of Medicines, Equipment and Medical Devices granted emergency approval to the Soberana 2 vaccine for the prevention of COVID-19, as reported in National Post.
-
Bonus BioGroup Receives Approval to Expand Phase-II Clinical Trials for its COVID-19 Treatment to Medical Centers Across Israel
firstwordpharma
August 23, 2021
Bonus BioGroup LTD or "the Company" (BONS.TA), an Israeli clinical-stage biotechnology company, has received official approval from the Israeli Ministry of Health to expand its phase II clinical trials for its MesenCure treatment to health centers.
-
UK scientists look at reducing boosters to save vaccine for rest of the world
firstwordpharma
August 23, 2021
Scientists in the UK are investigating whether smaller doses of COVID-19 vaccines could be used as part of booster programmes, stretching the supply of vaccines across the world, The Guardian reported Sunday.
-
South Korea to get more Moderna COVID shots in boost to vaccination effort
firstwordpharma
August 23, 2021
South Korea's health ministry said that Moderna will supply the country with 7.01 million doses of COVID-19 vaccines by the first week of September, as reported Sunday in Financial Post.